Year |
Citation |
Score |
2023 |
Macedo B, Patel M, Zaleski MH, Mody P, Ma X, Mei P, Myerson JW, Brenner JS, Glassman PM. Meta-Analysis of Material Properties Influencing Nanoparticle Plasma Pharmacokinetics. International Journal of Pharmaceutics. 122951. PMID 37059242 DOI: 10.1016/j.ijpharm.2023.122951 |
0.343 |
|
2021 |
Wang Z, Hood ED, Nong J, Ding J, Marcos-Contreras OA, Glassman PM, Rubey KM, Zaleski M, Espy CL, Gullipali D, Miwa T, Muzykantov VR, Song WC, Myerson JW, Brenner JS. Combating complement's deleterious effects on nanomedicine by conjugating complement regulatory proteins to nanoparticles. Advanced Materials (Deerfield Beach, Fla.). e2107070. PMID 34910334 DOI: 10.1002/adma.202107070 |
0.378 |
|
2021 |
Pietrofesa RA, Park K, Mishra OP, Johnson-McDaniel D, Myerson JW, Shuvaev VV, Arguiri E, Chatterjee S, Moorthy GS, Zuppa A, Hwang WT, Christofidou-Solomidou M. Copper Oxide Nanoparticle-Induced Acute Inflammatory Response and Injury in Murine Lung Is Ameliorated by Synthetic Secoisolariciresinol Diglucoside (LGM2605). International Journal of Molecular Sciences. 22. PMID 34502389 DOI: 10.3390/ijms22179477 |
0.309 |
|
2020 |
Glassman PM, Myerson JW, Ferguson LT, Kiseleva RY, Shuvaev VV, Brenner JS, Muzykantov VR. Targeting drug delivery in the vascular system: Focus on endothelium. Advanced Drug Delivery Reviews. PMID 32579890 DOI: 10.1016/J.Addr.2020.06.013 |
0.375 |
|
2019 |
Myerson JW, McPherson O, DeFrates KG, Towslee JH, Marcos-Contreras OA, Shuvaev VV, Braender B, Composto RJ, Muzykantov VR, Eckmann DM. Cross-linker-Modulated Nanogel Flexibility Correlates with Tunable Targeting to a Sterically Impeded Endothelial Marker. Acs Nano. PMID 31600053 DOI: 10.1021/Acsnano.9B04789 |
0.301 |
|
2019 |
Paek J, Park SE, Lu Q, Park KT, Cho M, Oh JM, Kwon KW, Yi YS, Song JW, Edelstein HI, Ishibashi J, Yang W, Myerson JW, Kiseleva RY, Aprelev P, et al. Microphysiological Engineering of Self-Assembled and Perfusable Microvascular Beds for the Production of Vascularized Three-Dimensional Human Microtissues. Acs Nano. PMID 31194909 DOI: 10.1021/Acsnano.9B00686 |
0.327 |
|
2019 |
Farokhirad S, Ranganathan A, Myerson J, Muzykantov VR, Ayyaswamy PS, Eckmann DM, Radhakrishnan R. Stiffness can mediate balance between hydrodynamic forces and avidity to impact the targeting of flexible polymeric nanoparticles in flow. Nanoscale. PMID 30912772 DOI: 10.1039/C8Nr09594A |
0.437 |
|
2019 |
Marcos-Contreras OA, Brenner JS, Kiseleva RY, Zuluaga-Ramirez V, Greineder CF, Villa CH, Hood ED, Myerson JW, Muro S, Persidsky Y, Muzykantov VR. Combining vascular targeting and the local first pass provides 100-fold higher uptake of ICAM-1-targeted vs untargeted nanocarriers in the inflamed brain. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30871995 DOI: 10.1016/J.Jconrel.2019.03.008 |
0.322 |
|
2018 |
Brenner JS, Pan DC, Myerson JW, Marcos-Contreras OA, Villa CH, Patel P, Hekierski H, Chatterjee S, Tao JQ, Parhiz H, Bhamidipati K, Uhler TG, Hood ED, Kiseleva RY, Shuvaev VS, et al. Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude. Nature Communications. 9: 2684. PMID 29992966 DOI: 10.1038/S41467-018-05079-7 |
0.315 |
|
2018 |
Myerson JW, Braender B, Mcpherson O, Glassman PM, Kiseleva RY, Shuvaev VV, Marcos-Contreras O, Grady ME, Lee HS, Greineder CF, Stan RV, Composto RJ, Eckmann DM, Muzykantov VR. Flexible Nanoparticles Reach Sterically Obscured Endothelial Targets Inaccessible to Rigid Nanoparticles. Advanced Materials (Deerfield Beach, Fla.). e1802373. PMID 29956381 DOI: 10.1002/Adma.201802373 |
0.407 |
|
2018 |
Pan DC, Myerson JW, Brenner JS, Patel PN, Anselmo AC, Mitragotri S, Muzykantov V. Nanoparticle Properties Modulate Their Attachment and Effect on Carrier Red Blood Cells. Scientific Reports. 8: 1615. PMID 29371620 DOI: 10.1038/S41598-018-19897-8 |
0.463 |
|
2017 |
Ranganathan A, Campo J, Myerson J, Shuvaev V, Zern B, Muzykantov V, Eckmann DM. Fluorescence Microscopy Imaging Calibration for Quantifying Nanocarrier Binding to Cells During Shear Flow Exposure. Journal of Biomedical Nanotechnology. 13: 737-745. PMID 29104516 DOI: 10.1166/Jbn.2017.2392 |
0.353 |
|
2016 |
Palekar RU, Jallouk AP, Myerson JW, Pan H, Wickline SA. Inhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 26769047 DOI: 10.1161/Atvbaha.115.306697 |
0.589 |
|
2015 |
Myerson JW, Anselmo AC, Liu Y, Mitragotri S, Eckmann DM, Muzykantov VR. Non-affinity factors modulating vascular targeting of nano- and microcarriers. Advanced Drug Delivery Reviews. PMID 26596696 DOI: 10.1016/J.Addr.2015.10.011 |
0.348 |
|
2015 |
Myerson JW, Brenner JS, Greineder CF, Muzykantov VR. Systems approaches to design of targeted therapeutic delivery. Wiley Interdisciplinary Reviews. Systems Biology and Medicine. PMID 25946066 DOI: 10.1002/Wsbm.1304 |
0.371 |
|
2015 |
Palekar RU, Jallouk AP, Goette MJ, Chen J, Myerson JW, Allen JS, Akk A, Yang L, Tu Y, Miller MJ, Pham CT, Wickline SA, Pan H. Quantifying progression and regression of thrombotic risk in experimental atherosclerosis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 29: 3100-9. PMID 25857553 DOI: 10.1096/Fj.14-269084 |
0.709 |
|
2014 |
Myerson JW, He L, Allen JS, Williams T, Lanza G, Tollefsen D, Caruthers S, Wickline S. Thrombin-inhibiting nanoparticles rapidly constitute versatile and detectable anticlotting surfaces. Nanotechnology. 25: 395101. PMID 25200815 DOI: 10.1088/0957-4484/25/39/395101 |
0.622 |
|
2014 |
Bibee KP, Cheng YJ, Ching JK, Marsh JN, Li AJ, Keeling RM, Connolly AM, Golumbek PT, Myerson JW, Hu G, Chen J, Shannon WD, Lanza GM, Weihl CC, Wickline SA. Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac function. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 28: 2047-61. PMID 24500923 DOI: 10.1096/Fj.13-237388 |
0.712 |
|
2014 |
Pan H, Myerson J, Yang X, Lanza G, Wickline SA. Atherosclerosis endothelial activation quantification in vivo with fluorine magnetic resonance imaging and spectroscopy Journal of Cardiovascular Magnetic Resonance. 16. DOI: 10.1186/1532-429X-16-S1-O91 |
0.619 |
|
2013 |
Palekar RU, Myerson JW, Schlesinger PH, Sadler JE, Pan H, Wickline SA. Thrombin-targeted liposomes establish a sustained localized anticlotting barrier against acute thrombosis. Molecular Pharmaceutics. 10: 4168-75. PMID 24063304 DOI: 10.1021/Mp400210Q |
0.563 |
|
2013 |
Pan H, Myerson JW, Hu L, Marsh JN, Hou K, Scott MJ, Allen JS, Hu G, San Roman S, Lanza GM, Schreiber RD, Schlesinger PH, Wickline SA. Programmable nanoparticle functionalization for in vivo targeting. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 27: 255-64. PMID 23047896 DOI: 10.1096/Fj.12-218081 |
0.705 |
|
2012 |
Myerson JW, Allen JS, Williams TA, He L, Tollefsen DM, Lanza G, Caruthers SD, Wickline SA. PPACK and Bivalirudin nanoparticles enable simultaneous imaging and potent inhibition of acute clotting Journal of Cardiovascular Magnetic Resonance. 14. DOI: 10.1186/1532-429X-14-S1-O41 |
0.576 |
|
2011 |
Zhang H, Zhang L, Myerson J, Bibee K, Scott M, Allen J, Sicard G, Lanza G, Wickline S. Quantifying the evolution of vascular barrier disruption in advanced atherosclerosis with semipermeant nanoparticle contrast agents. Plos One. 6: e26385. PMID 22028868 DOI: 10.1371/Journal.Pone.0026385 |
0.712 |
|
2011 |
Myerson J, He L, Lanza G, Tollefsen D, Wickline S. Thrombin-inhibiting perfluorocarbon nanoparticles provide a novel strategy for the treatment and magnetic resonance imaging of acute thrombosis. Journal of Thrombosis and Haemostasis : Jth. 9: 1292-300. PMID 21605330 DOI: 10.1111/J.1538-7836.2011.04339.X |
0.594 |
|
2010 |
Pan H, Myerson JW, Ivashyna O, Soman NR, Marsh JN, Hood JL, Lanza GM, Schlesinger PH, Wickline SA. Lipid membrane editing with peptide cargo linkers in cells and synthetic nanostructures. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 2928-37. PMID 20335225 DOI: 10.1096/Fj.09-153130 |
0.577 |
|
2010 |
Myerson JW, Kaneda MM, Lanza GM, Wickline SA. 19F MRS assessment of siRNA delivery to vascular cells via perfluorocarbon nanoparticles Journal of Cardiovascular Magnetic Resonance. 12. DOI: 10.1186/1532-429X-12-S1-P103 |
0.756 |
|
2010 |
Myerson JW, He L, Tollefsen DM, Wickline SA. Thrombin inhibitor perfluorocarbon nanoparticles for treatment and 19F tracking of acute thrombosis Journal of Cardiovascular Magnetic Resonance. 12. DOI: 10.1186/1532-429X-12-S1-O60 |
0.564 |
|
2009 |
Cai K, Zhang L, Myerson J, Huang W, Caruthers SD, Lanza GM, Wickline SA, Winter PM. Dual PARACEST and 19F MR molecular imaging of fibrin clots with targeted perfluorocarbon nanoparticles Journal of Cardiovascular Magnetic Resonance. 11. DOI: 10.1186/1532-429X-11-S1-T6 |
0.687 |
|
2008 |
Neubauer AM, Myerson J, Caruthers SD, Hockett FD, Winter PM, Chen J, Gaffney PJ, Robertson JD, Lanza GM, Wickline SA. Gadolinium-modulated 19F signals from perfluorocarbon nanoparticles as a new strategy for molecular imaging. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 60: 1066-72. PMID 18956457 DOI: 10.1002/Mrm.21750 |
0.728 |
|
2008 |
Centrone A, Penzo E, Sharma M, Myerson JW, Jackson AM, Marzari N, Stellacci F. The role of nanostructure in the wetting behavior of mixed-monolayer-protected metal nanoparticles. Proceedings of the National Academy of Sciences of the United States of America. 105: 9886-91. PMID 18621710 DOI: 10.1073/Pnas.0803929105 |
0.424 |
|
2004 |
Jackson AM, Myerson JW, Stellacci F. Spontaneous assembly of subnanometre-ordered domains in the ligand shell of monolayer-protected nanoparticles. Nature Materials. 3: 330-6. PMID 15098025 DOI: 10.1038/Nmat1116 |
0.308 |
|
Show low-probability matches. |